AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma

Qing Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuchen Jiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhewen Wei(Chinese Academy of Medical Sciences & Peking Union Medical College), Junbo Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yarui Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Mei Liu(Bennett Aerospace (United States)), Mo Li(University of Oxford), Xiaobing Wang(Shanghai Changzheng Hospital), Huan He(Kunming University of Science and Technology), Jianqiang Cai(Chinese Academy of Medical Sciences & Peking Union Medical College), Chunfeng Qu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Signal Transduction and Targeted Therapy
August 9, 2021
10.1038/s41392-021-00713-1
Cited by 122

Related Papers

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709